Marketing-authorisation holder
Ortho Mcneil Pharm
38 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
38 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 38
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CLISTIN4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Carbinoxamine | United States | Not marketed | |
| DIENESTROL0.01% · Cream | Dienestrol | United States | Not marketed | 1947 |
| FLOXIN20mg/ml | 40mg/ml · Injectable | Ofloxacin | United States | Not marketed | 1992 |
| FLOXIN IN DEXTROSE 5%400mg/100ml · Injectable | Ofloxacin | United States | Not marketed | 1992 |
| FLOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER400mg/100ml | 4mg/ml · Injectable | Ofloxacin | United States | Not marketed | 1992 |
| HALDOL2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Concentrate | Haloperidol | United States | Not marketed | 1967 |
| HALDOL0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register d · Tablet | Haloperidol | United States | Not marketed | 1967 |
| HALDOL SOLUTAB1MG · Tablet | Haloperidol | United States | Not marketed | |
| INJECTAPAP100mg/ml · Injectable | Paracetamol | United States | Not marketed | |
| MODICON 210.035MG; 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1974 |
| NORCEPT-E 1/35 210.035mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1989 |
| NORCEPT-E 1/35 280.035mg; 1mg · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1989 |
| ORTHO-NOVUM 1/35-210.035MG; 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1974 |
| ORTHO-NOVUM 1/50 210.05mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1962 |
| ORTHO-NOVUM 1/80 210.08mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | |
| ORTHO-NOVUM 1/80 280.08mg; 1mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | |
| ORTHO-NOVUM 10-210.06mg; 10mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1962 |
| ORTHO-NOVUM 2-210.1mg; 2mg · Tablet | Mestranol, Norethindrone | United States | Not marketed | 1962 |
| ORTHO-NOVUM 7/14-210.035MG,0.035MG; 0.5MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1984 |
| ORTHO-NOVUM 7/14-280.035MG,0.035MG; 0.5MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ethinyl estradiol, Norethindrone | United States | Not marketed | 1984 |
| ORTHO TRI-CYCLEN 210.035mg,0.035mg,0.035mg; 0.18mg,0.215mg,0.25mg · Tablet | Ethinyl estradiol, Norgestimate | United States | Marketed | 2005 |
| ORTHO TRI-CYCLEN 280.035mg,0.035mg,0.035mg; 0.18mg,0.215mg,0.25mg · Tablet | Ethinyl estradiol, Norgestimate | United States | Marketed | 2005 |
| PARAFLEX250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Chlorzoxazone | United States | Not marketed | |
| PROTOSTAT250mg | 500mg · Tablet | Metronidazole | United States | Not marketed | 1983 |
| SALPIX53% · Solution | Acetrizoate | United States | Not marketed | 1953 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 38 | 38 | 0 | CompaniesAll medicines |
Also in the registers of Canada
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.